Post-Angioplasty Recovery Guidelines
After uncomplicated PCI, patients can begin walking the following day and ambulate on flat surfaces and stairs within a few days, with continuous cardiac monitoring discontinued immediately after femoral sheath removal in the post-procedure area 1.
Immediate Post-Procedure Monitoring (First 6-24 Hours)
For Uncomplicated PCI
- Monitoring duration: Continuous ECG monitoring only until femoral sheath removal, then discontinue 1
- Most major complications occur within the first 6 hours and decline thereafter
- Vasovagal responses with symptomatic bradycardia can occur during femoral sheath removal, justifying monitoring until this point
- No benefit to continued monitoring beyond sheath pull in uncomplicated cases 1
For Complicated PCI
If vessel dissection, no-reflow, suboptimal stent apposition, or under-expansion occurred:
- Continue monitoring for ≥24 hours for both arrhythmia and ischemia 1
- Watch for chest pain, ECG changes, MI, and hemodynamic instability
- Subacute closure can occur with median time of 24 hours
Medication Regimen
Antiplatelet Therapy (Critical)
Aspirin: Continue indefinitely 2, 3
Clopidogrel duration depends on stent type 4, 5, 6:
- Bare-metal stent (BMS): Minimum 4-6 weeks (ideally 3-4 months)
- Drug-eluting stent (DES) for stable disease: 6 months minimum
- DES for acute coronary syndrome: 12 months minimum 6
Critical timing consideration: If elective surgery is needed 4, 5:
- After balloon angioplasty alone: Wait ≥14 days
- After BMS: Wait 4-6 weeks (allows endothelialization), but not >12 weeks (restenosis risk)
- After DES for stable disease: Wait ≥6 months
- After DES for ACS: Wait ≥12 months
Anticoagulation
- Discontinue after uncomplicated PCI 2
- Continue unfractionated heparin only if complications occurred
Additional Medications
- Beta-blockers: Continue if already prescribed for angina, arrhythmias, or hypertension 7
- Statins: Initiate or continue; recheck lipids at 4-6 weeks post-ACS, then at 3 months 8
- Monitor for muscle symptoms at each visit; check liver enzymes initially, 8-12 weeks after initiation, and after dose increases
Activity Restrictions
Timeline for Physical Activity 8
- Day 1 post-procedure: Begin walking on flat surfaces
- Days 2-3: Walk stairs, increase distance
- Within 7 days: Baseline physical examination and assessment
- Cardiac rehabilitation: Start after clinical stabilization in patients with significant myocardial damage
Specific Restrictions
- Avoid heavy lifting (>10 lbs) for 48 hours after femoral access
- No driving for 24 hours post-procedure
- Sexual activity can resume after 3-5 days if no complications
- Return to work timing depends on occupation: desk work within days, manual labor after 1-2 weeks
Wound Care (Femoral Access Site)
Immediate Care 9
- Bed rest: 2 hours supine after sheath removal 10
- Mobilization protocol: Gradual mobilization starting at 2 hours, fully ambulant by 4 hours in 90% of cases 10
- Apply pressure dressing for 2-4 hours
- Keep access site clean and dry for 24 hours
Expected Findings
- Small hematomas (<2.5 cm) occur in 26% and are not concerning 10
- Mild bruising is normal
Monitoring at Home
- Check site daily for first 3 days
- Keep area clean; may shower after 24 hours (no baths for 48 hours)
- Avoid hot tubs/swimming for 1 week
Signs Requiring Urgent Evaluation
Return to Emergency Department Immediately If:
Access site complications:
- Rapidly expanding hematoma (>7.5 cm)
- Active bleeding not controlled by 10 minutes of direct pressure
- New pulsatile mass at puncture site (pseudoaneurysm)
- Numbness, tingling, or coldness in affected leg
Cardiac symptoms:
- Chest pain similar to or worse than pre-procedure angina
- Chest pain lasting >5 minutes despite rest
- Severe shortness of breath
- Palpitations with lightheadedness
Systemic symptoms:
- Fever >38°C (100.4°F)
- Severe back pain (may indicate retroperitoneal bleeding)
- Syncope or near-syncope
Follow-Up Schedule
Within 7 Days 8
- Physical examination
- Resting ECG
- Laboratory testing: CBC (check for anemia), creatinine (assess for contrast-induced nephropathy)
- Puncture site assessment
4-6 Weeks (Post-ACS) 8
- Lipid panel reassessment
- Liver function tests if on statins
- Medication review and adherence assessment
3 Months 8
- Second lipid panel to confirm target achievement
- Functional assessment
- Consider stress testing if symptoms recur
Stress Testing Indications 8
Do NOT perform routine stress testing in asymptomatic patients
Consider stress imaging (NOT stress ECG alone) if 8:
- Symptoms recur 1-8 months post-procedure (suggests restenosis)
- Incomplete or suboptimal revascularization was performed
- High-risk patient subsets
2 years after PCI or >5 years after CABG in select cases
Common Pitfalls to Avoid
Premature clopidogrel discontinuation: This is the leading cause of stent thrombosis, which results in MI or death in the majority of cases 4
Stopping aspirin perioperatively: Continue aspirin even for surgery unless bleeding risk is prohibitive; stopping both antiplatelet agents dramatically increases thrombosis risk 4, 2
Routine stress testing: Provides no benefit in asymptomatic patients and may lead to unnecessary interventions 8
Ignoring contrast nephropathy risk: Peak creatinine elevation occurs 3-5 days post-procedure; ensure adequate hydration and monitor renal function 11
Premature mobilization in complicated cases: The 4-hour mobilization protocol applies only to uncomplicated cases; 10% require prolonged bed rest 10